Superworth

Medifast MED

Packaged Foods, Consumer Defensive
$12.53
+3.13%
Market cap
$140.1M
PE
n/m
a loss over the last year
Forward PE
n/m
not a meaningful number
Price to sales
0.5×
EV/EBIT
n/m
a loss over the last year
Revenue, 12 months
$299.6M
−30% on a year ago
Net margin
−13.6%
Free cash flow yield
−2.8%

Medifast trades at 0.5× sales. Its trailing earnings are negative, so it has no PE. Revenue was $299.6M over the last twelve months, down 30% on a year earlier with a −14% net margin.

Charts

Financials

Income statement for MED, by quarter
Income statementQ4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
$191M−43%$174.7M−50%$168.6M−43%$140.2M−41%$119M−38%$115.7M−34%$105.6M−37%$89.4M−36%$75.1M−37%$76M−34%$76.4M−28%$72M−19%
Cost of revenue$49.6M−52%$47.4M−54%$45.1M−47%$34.5M−41%$30.8M−38%$31.5M−34%$28.9M−36%$27.3M−21%$23M−25%$24.3M−23%$23M−21%$22M−19%
Gross profit$141.4M−40%$127.3M−48%$123.4M−41%$105.7M−40%$88.2M−38%$84.2M−34%$76.6M−38%$62.2M−41%$52.1M−41%$51.8M−39%$53.4M−30%$50M−20%
SG&A$132.7M−34%$119.4M−38%$131.3M−24%$103.6M−32%$87.5M−34%$85.5M−28%$77.7M−41%$66.2M−36%$59.9M−32%$55.1M−36%$57.7M−26%$69.4M+5%
$8.7M−73%$7.9M−85%−$7.9M$2.1M−92%$709K−92%−$1.3M−$1.1M−87%−$4.1M−$7.8M−$3.3M+161%−$4.3M+306%−$19.4M+374%
Interest expensen/an/an/an/an/an/an/an/an/an/an/an/a
Pre-tax income$9.8M−70%$11.6M−78%−$10.7M$1.6M−94%$1.3M−87%$526K−96%$2.9M−$2.7M−$6.4M−$1.9M−$3M−$17.8M+571%
$3.8M−36%$3.3M−76%−$2.5M$449K−87%$474K−87%$1.3M−60%$395K−$396K$11.7M+2376%$181K−86%$109K−72%−$324K−18%
Net income$6M−77%$8.3M−79%−$8.2M$1.1M−95%$801K−87%−$772K$2.5M−$2.3M−$18.1M−$2.1M+175%−$3.1M−$17.5M+675%
$0.55−77%$0.76−79%−$0.75$0.10−95%$0.07−87%−$0.07$0.22−$0.21−$1.65−$0.19+171%−$0.28−$1.57+648%
10.9M−1%11M+1%10.9M+0%11M+0%11M+1%10.9M−0%11.1M+1%11M+0%11M+0%11M+1%11.1M+1%11.2M+2%

EPS, diluted: 11 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: 14 periods, Q4 FY10 to Q4 FY24: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY14 and Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Packaged Foods nearest Medifast's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
MEDMedifast$140.1Mn/m23.3×0.5×−30%−13.6%
LWAYLifeway Foods$336.5M31.8×31.2×1.4×+26%4.5%
MAMAMama's Creations$606.8M75.7×58.2×2.9×+54%3.5%
JVACoffee$28.7M6.1×22.9×0.3×+8%4.9%
SENEASeneca Foods$1.1B9.2×8.9×0.6×+12%6.7%
BRBRBellring Brands$1.1B6.7×34.9×0.5×+6%7.3%
Peer median$606.8M9.2×31.2×0.6×+12%4.9%

More on Medifast

Each number over time

Where it ranks

Its groups

About

Industry
Packaged Foods
Sector
Consumer Defensive

Valuation data, not investment advice. Prices as of .